D. Bonzo

The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors

A. al‐Sabbagh, C. Hermans, C. Leissinger, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.

K. Zomorodi, Dan Chen, R. Lal, 2012, Clinical therapeutics.

Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors

C. Hermans, Michael Wang, M. Carcao, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors

J. Luck, A. al‐Sabbagh, C. Hermans, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma

J. Grandoni, S. Evans, D. Bonzo, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Assess the Pharmacokinetics, Efficacy, and Safety of Gabapentin Enacarbil in Subjects With Restless Legs Syndrome

K. Zomorodi, A. Ellenbogen, Dan Chen, 2012, Clinical neuropharmacology.

The Validity of the Neuropathic Pain Scale for Assessing Diabetic Neuropathic Pain in a Clinical Trial

M. Jensen, M. Friedman, D. Bonzo, 2006, The Clinical journal of pain.

Pain relief with Eptacog beta in haemophilia patients with inhibitors

C. Hermans, M. Carcao, M. Witkop, 2023, GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark.